Stay updated on Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice above the 403 error page announces NIH website updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T03:08:03.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T02:54:05.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T03:54:28.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record details, indicating that access to the trial information at this URL is blocked.
    Difference
    21%
    Check dated 2026-09-20T02:05:13.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Related topic links for Multiple myeloma and MedlinePlus Genetics were added to the page, expanding disease context and genetics resources for readers.
    Difference
    0.1%
    Check dated 2026-09-06T00:07:21.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new page revision tag 'Revision: v3.6.6' is added and the older tag 'Revision: v3.6.5' is removed. Related topics such as 'Multiple myeloma' and 'MedlinePlus Genetics' are removed from the page's related topics.
    Difference
    0.2%
    Check dated 2026-08-30T00:38:50.000Z thumbnail image

Stay in the know with updates to Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perseus Study: Daratumumab vs Standard in Untreated Myeloma Clinical Trial page.